pubmed-article:16418308 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0278883 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0010927 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
pubmed-article:16418308 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:16418308 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16418308 | pubmed:dateCreated | 2006-3-24 | lld:pubmed |
pubmed-article:16418308 | pubmed:abstractText | This randomized phase III trial was designed to demonstrate the superiority of autologous peptide-loaded dendritic cell (DC) vaccination over standard dacarbazine (DTIC) chemotherapy in stage IV melanoma patients. | lld:pubmed |
pubmed-article:16418308 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16418308 | pubmed:language | eng | lld:pubmed |
pubmed-article:16418308 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16418308 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16418308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16418308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16418308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16418308 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16418308 | pubmed:month | Apr | lld:pubmed |
pubmed-article:16418308 | pubmed:issn | 0923-7534 | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:AVISK EKE | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:BergerTT | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:SchulerGG | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:RittgenWW | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:BeckerJ CJC | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:EdlerLL | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:KämpgenEE | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:GrabbeSS | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:SchadendorfDD | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:LIJ TJT | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:NestleF OFO | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:JonuleitHH | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:KeikavoussiPP | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:KamarashevJJ | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:UgurelSS | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:SuckerAA | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:Schuler-Thurn... | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:BröckerE-BEB | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:Zimpfer-Rechn... | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:TüttenbergAA | lld:pubmed |
pubmed-article:16418308 | pubmed:author | pubmed-author:DC study... | lld:pubmed |
pubmed-article:16418308 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16418308 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:16418308 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16418308 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16418308 | pubmed:pagination | 563-70 | lld:pubmed |
pubmed-article:16418308 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:meshHeading | pubmed-meshheading:16418308... | lld:pubmed |
pubmed-article:16418308 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16418308 | pubmed:articleTitle | Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. | lld:pubmed |
pubmed-article:16418308 | pubmed:affiliation | Skin Cancer Unit, German Cancer Research Center & University Hospital Mannheim, Mannheim. d.schadendorf@dkfz.de | lld:pubmed |
pubmed-article:16418308 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16418308 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16418308 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16418308 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16418308 | lld:pubmed |